Schedule 13G ownership disclosure

EUROPEAN BIOTECH ACQUTN CORP

Security class unavailable · CUSIP: G3167F102

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-035718
Form type
SC 13G
Filer
European Biotech Acquisition Corp.
CIK
CIK 1841258
Filed
Feb 13, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub